This level of selling is routine for a company of this size and not a material red flag. Traders should monitor for recurrence or larger divestitures, but no immediate action is warranted.
PCVX drugs
PCVX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 1 $58.50entry
- T+1 · 8mo ago −0.21%α −0.28% · $58.38
- T+5 · 7mo ago +5.45%α +1.69% · $61.69
- T+20 · 7mo ago −2.02%α −11.74% · $57.32
- T+60 · 5mo ago −1.33%α −14.71% · $57.72
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Vaxcyte executives sold shares in the past week, including COO Jim Wassil selling $82K and SVP Elvia selling $180K after exercising options. The total cluster value is $262K, representing 0.003% of market cap, a routine, modest-sized insider selling event.
Key Financial Metrics
Key Facts
- Chief Operating Officer Jim Wassil sold $82,000 worth of shares in an open-market transaction.
- SVP and CAO Elvia Cowan sold $180,000 in shares, following the exercise of 6,000 derivative securities (3,000 exercised at $0, 3,000 at $25.92).
- Total insider selling cluster value: $262,000 over a 7-day window.
- No insider purchases or grants; net direction is selling.
- Cluster represents only 0.003% of Vaxcyte's $8.7B market cap.
Financial Impact
$262,000 in open-market share sales over 7 days
Risk Factors
- Perception of insider skepticism if selling continues in coming weeks
- Potential for negative sentiment if no offsetting positive news emerges
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PCVX-1775680392851 |
Track record
29 reports on PCVX
5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +10.87% at T+5 after the Oct 8, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $62.40 Now $63.37 +1.55% settles Dec 15
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $64.69 Now $63.37 −2.04% settles Dec 11
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $63.89 Now $63.37 −0.81% settles Dec 7
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $63.89 Now $63.37 −0.81% settles Dec 7
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $61.92 Now $63.37 +2.34% settles Dec 4
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $61.92 Now $63.37 +2.34% settles Dec 4
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $60.81 Now $63.37 +4.21% settles Dec 2
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $60.81 Now $63.37 +4.21% settles Dec 2
- Oct 9, 20265w ago 8-K Bearish 6/10 Entry $70.65 to $67.53 Now $63.37 +10.30% ▲ +4.42% +1.15% vs SPY
- Oct 8, 20265w ago 424B5 Bearish 6/10 Entry $71.38 to $63.89 Now $63.37 +11.22% ▲ +10.49% +4.93% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers